Frequent activation of CArG binding factor-A expression and binding in N-methyl-N-nitrosourea-induced rat mammary carcinomas

Breast Cancer Research and Treatment

Volumn 88, Issue 1, 2004, Pages 95-102

  Mikheev, Andrei M ^a   Inoue, Akira ^b   Jing, Lichen ^a   Mikheeva, Svetlana A ^c   Li, Vivian ^a   Leanderson, Tomas ^d   Zarbl, Helmut ^a  

^a USA   (United States)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF WASHINGTON   (United States)

^d LUND UNIVERSITY   (Sweden)

Author keywords

CArG binding factor A; heterogeneous nuclear ribonuclear protein; mammary tumor

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; METHYLNITROSOUREA; PROTEIN SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; NONHUMAN; ONCOGENE H RAS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RNA TRANSLATION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; TUMOR GROWTH;

EID: 8744220668     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-004-1280-5     Document Type: Article

References (28)

1. Kamada S, Miwa T: A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor. Gene 119: 229-236, 1992
2. Catala F, Wanner R, Barton P, Cohen A, Wright W, Buckingham M: A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene. Mol Cell Biol 15: 4585-4596, 1995
3. Madsen CS, Regan CP, Owens GK: Interaction of CArG elements and a GC-rich repressor element in transcriptional regulation of the smooth muscle myosin heavy chain gene in vascular smooth muscle cells. J Biol Chem 272: 29842-29851, 1997
4. Zilberman A, Dave V, Miano J, Olson EN, Periasamy M: Evolutionarily conserved promoter region containing CArG*-like elements is crucial for smooth muscle myosin heavy chain gene expression. Circ Res 82: 566-575, 1998
5. Mack CP, Owens GK: Regulation of smooth muscle alpha-actin expression in vivo is dependent on CArG elements within the 5′ and first intron promoter regions. Circ Res 84: 852-861, 1999
6. Galvagni F, Cartocci E, Oliviero S: The dystrophin promoter is negatively regulated by YY1 in undifferentiated muscle cells. J Biol Chem 273: 33708-33713, 1998
7. Soulez M, Tuil D, Kahn A, Gilgenkrantz H: The serum response factor (SRF) is needed for muscle-specific activation of CArG boxes. Biochem Biophys Res Commun 219: 418-422, 1996
8. Martin KA, Gualberto A, Kolman MF, Lowry J, Walsh K: A competitive mechanism of CArG element regulation by YY1 and SRF: implications for assessment of Phox1/MHox transcription factor interactions at CArG elements. DNA Cell Biol 16: 653-661, 1997
9. Krecic AM, Swanson MS: hnRNP complexes: composition, structure, and function. Curr Opin Cell Biol 11: 363-371, 1999
10. Cartegni L, Maconi M, Morandi E, Cobianchi F, Riva S, Biamonti G: hnRNP A1 selectively interacts through its Gly-rich domain with different RNA-binding proteins. J Mol Biol 259: 337-348, 1996
11. Mikheev AM, Mikheev SA, Zhang Y, Aebersold R, Zarbl H: CArG binding factor A (CBF-A) is involved in transcriptional regulation of the Ha-ras promoter. Nucl Acid Res 28: 3762-3770, 2000
12. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acid Res 11: 1475-1489, 1983
13. Cartwright M, Mikheev AM, Heinrich G: Expression of neurotrophin genes in human fibroblasts: differential regulation of the brain-derived neurotrophic factor gene. Int J Develop Neurosci 12: 685-693, 1994
14. Bemark M, Olsson H, Heinegård D, Leanderson T: Purification and characterization of a protein binding to the SP6 kappa promoter. A potential role for CArG-box binding factor-A in kappa transcription. J Biol Chem 273: 18881-18890, 1998
15. Inoue A, Omori A, Ichinose S, Takahashi KP, Kinoshita Y, Mita S: S1 proteins C2 and D2 are novel hnRNPs similar to the transcriptional repressor, CArG box motif-binding factor A. Eur J Biochem 268: 3654-3663, 2001
16. Cha RS, Thilly WG, Zarbl H: N-nitroso-N-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hrasl gene mutations. Proc Natl Acad Sci USA 91: 3749-3753, 1994
17. Finney RE, Bishop JM: Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science 260: 1524-1527, 1993
18. Zarbl H, Sukumar S, Arthur AV, Martin-Zanca D, Barbacid M: Direct mutagenesis of Ha-ras-1 oncogenes by N-nitroso-N-methylurea during initiation of mammary carcinogenesis in rats. Nature 315: 382-385, 1985
19. Tockman MS, Mulshine JL, Piantadosi S, Erozan YS, Gupta PK, Ruckdeschel JC, Taylor PR, Zhukov T, Zhou WH, Qiao YL, Yao SX: Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin Cancer Res 3: 2237-2246, 1997
20. Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujiki H: Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers. Cancer Res 59: 1404-1407, 1999
21. Goto Y, Sueoka E, Chiba H, Fujiki H: Significance of heterogeneous nuclear ribonucleoprotein B1 as a new early detection marker for oral squamous cell carcinoma. Jap J Cancer Res 90: 1358-1363, 1999
22. Matsuyama S, Goto Y, Sueoka N, Ohkura Y, Tanaka Y, Nakachi K, Sueoka E: Heterogeneous nuclear ribonucleoprotein B1 expressed in esophageal squamous cell carcinomas as a new biomarker for diagnosis. Jap J Cancer Res 91: 658-663, 2000
23. Mandal M, Vadlamudi R, Nguyen D, Wang RA, Costa L, Bagheri_Yarmand R, Mendelsohn J, Kumar R: Growth factors regulate heterogeneous nuclear ribonucleoprotein K expression and function. J Biol Chem 276: 9699-9704, 2001
24. Zhou J, Allred DC, Avis I, Martinez A, Vos MD, Smith L, Treston AM, Mulshine JL: Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer. Breast Cancer Res Treat 66: 217-224, 2001
25. Yan-Sanders Y, Hammons GJ, Lyn-Cook BD: Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. Cancer Lett 183: 215-220, 2002
26. Robinson L, Panayiotakis A, Papas TS, Kola I, Seth A: ETS target genes: identification of egr1 as a target by RNA differential display and whole genome PCR techniques. Proc Natl Acad Sci USA 94: 7170-7175, 1997
27. Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D: A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice. Cancer Res 62: 1489-1495, 2002
28. Jin Z, Houle B, Mikheev AM, Cha RS, Zarbl H: Alterations in H-ras1 promoter conformation during N-nitroso-N-methylurea-induced mammary carcinogenesis and pregnancy. Cancer Res 56: 4927-4935, 1996